¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"subcortical arteriosclerotic encephalopathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acute necrotizing hemorrhagic encephalopathy
    ±Þ¼º±«»çÃâÇ÷³úº´(Áõ)
  • bilirubin encephalopathy
    ºô¸®·çºó³úº´(Áõ)
  • demyelinating encephalopathy
    ¸»ÀÌÁýÅ»¶ô³úº´(Áõ), Å»¼öÃʳúº´(Áõ)
  • encephalopathy
    ³úº´(Áõ)
  • hypertensive encephalopathy
    °íÇ÷¾Ð³úº´(Áõ)
  • hypoglycemic encephalopathy
    ÀúÇ÷´ç³úº´(Áõ)
  • hypoxic encephalopathy
    Àú»ê¼Ò³úº´(Áõ)
  • ischemic encephalopathy
    ÇãÇ÷³úº´(Áõ)
  • lead encephalopathy
    ³³Áßµ¶³úº´(Áõ)
  • necrotizing encephalopathy
    ±«»ç³úº´(Áõ)
  • portal-systemic encephalopathy
    ¹®¸ÆÀü½Å¼øÈ¯(¼º)³úº´(Áõ)
  • saturnine encephalopathy
    ³³Áßµ¶³úº´(Áõ)
  • spongiform encephalopathy
    ÇØ¸é¸ð¾ç³úº´(Áõ), °¹¼ØÇü³úº´(Áõ)
  • uremic encephalopathy
    ¿äµ¶³úº´(Áõ)
  • Wernicke encephalopathy
    º£¸£´ÏÄɳúº´(Áõ)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bilirubin encephalopathy
    ºô¸®·çºó³úº´Áõ
  • demyelinating encephalopathy
    ¸»ÀÌÁýÅ»¶ô³úº´Áõ
  • encephalopathy
    ³úº´Áõ
  • hyperglycemic encephalopathy
    °ú´ÙÇ÷´ç³úº´Áõ
  • hypertensive encephalopathy
    °íÇ÷¾Ð³úº´Áõ
  • hypoglycemic encephalopathy
    ÀúÇ÷´ç³úº´Áõ
  • hypoxic encephalopathy
    Àú»ê¼Ò³úº´Áõ
  • ischemic encephalopathy
    ÇãÇ÷³úº´Áõ
  • necrotizing encephalopathy
    ±«»ç³úº´Áõ
  • portal-systemic encephalopathy
    ¹®¸ÆÀü½Å¼øÈ¯³úº´Áõ
  • posttraumatic encephalopathy
    ¿Ü»óÈijúº´Áõ
  • saturnine encephalopathy
    ³³Áßµ¶³úº´Áõ
  • spongiform encephalopathy
    °¹¼ØÇü³úº´Áõ, ÇØ¸é³úº´Áõ
  • traumatic encephalopathy
    ¿Ü»ó³úº´Áõ
  • uremic encephalopathy
    ¿äµ¶Áõ³úº´Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • arteriosclerotic heart disease
    µ¿¸Æ°æÈ­¼º ½ÉÁúȯ(ãýòðü´).
  • arteriosclerotic kidney
    µ¿¸Æ°æÈ­¼º ½Å (¡­ãì).
  • arteriosclerotic nephritis
    µ¿¸Æ°æÈ­¼º ½Å¿°(¡­ãìæú).
  • arteriosclerotic nephrosclerosis
    µ¿¸Æ°æÈ­¼º ½Å°æÈ­Áõ(¡­ãìÌãûùñø).
  • arteriosclerotic psychosis
    µ¿¸Æ°æÈ­¼º Á¤½ÅÁõ(º´)
  • arteriosclerotic psychosis
    µ¿¸Æ°æÈ­¼º Á¤½Åº´.
  • retinomalacia, arteriosclerotic
    µ¿¸Æ°æÈ­¼º(ÔÑØæÌãûùàõ) ¸Á¸·¿¬È­Áõ(¡­æãûùñø)
  • saccular arteriosclerotic aortic aneurysm
    ÁָӴϸð¾çµ¿¸Æ°æÈ­¼º ´ëµ¿¸Æ·ù(¡­Ù¼åÆÔÑØæÌãûùàõÓÞÔÑØæ×»).
  • saccular arteriosclerotic aortic aneurysm
    ÁָӴϸð¾çµ¿¸Æ°æÈ­¼º ´ëµ¿¸Æ·ù(¡­Ù¼åÆÔÑØæÌãûùàõÓÞÔÑØæ×»)
  • acute hypoxic encephalopathy
    ±Þ¼º Àú»ê¼Ò¼º ³úº´Áõ(¡­î¸ß«áÈàõÒàÜ»ñø).
  • alcoholic encephalopathy
    ¾ËÄڿüº ³ú(º´)Áõ(¡­ÒàÜ»ñø).
  • ammonia, in hepatic encephalopathy
    ¾Ï¸ð´Ï¾Æ, °£¼º ³úº´Áõ(ÊÜàõ ÒàÜ»ñø)
  • bovine spongiform encephalopathy(BSE)
    ¼ÒÇØ¸é¾ç³úÁõ
  • demyelinating encephalopathy
    Å»¼öÃÊ(¼º) ³úº´Áõ(÷­âÐôúàõÒàÜ»ñø).
  • encephalopathy
    ³úº´Áõ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SCWM subcortical white matter
AHD acquired hepatocerebral degeneration; acute heart disease; antihyaluronidase; antihypertensive drug;...
AOD Academy of Operative Dentistry; Academy of Oral Dynamics; adult onset diabetes; anesthesiologist-on-...
ASCVD arteriosclerotic cardiovascular disease; atherosclerotic cardiovascular disease
ASHD arteriosclerotic heart disease; atrioseptal heart disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HIE Hypoxic ischaemic encephalopathy
PSE Portal systemic encephalopathy
SHE Subclinical hepatic encephalopathy
TSE Transmissible Spongiform Encephalopathy
TME Transmissible mink encephalopathy
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
metabolic encephalopathy Encephalopathy characterised by memory loss, vertigo, and generalised weakness, due to metabolic brain disease including hypoxia, ischemia, hypoglycaemia, or secondary to other organ failure such as liver or kidney.
(05 Mar 2000)
Wernicke-Korsakoff encephalopathy See: Wernicke's syndrome, Korsakoff's syndrome.
(05 Mar 2000)
Wernicke's encephalopathy <neurology> Encephalopathy associated with thiamin deficiency. Usually associated with chronic alcohol abuse. Other features include loss of memory and confabulation.
Origin: Gr. Pathos = disease
(27 Sep 1997)
portal-systemic encephalopathy An encephalopathy associated with cirrhosis of the liver, attributed to the passage of toxic nitrogenous substances from the portal to the systemic circulation; cerebral manifestations may include coma.
Synonym: hepatic encephalopathy.
(05 Mar 2000)
hepatic encephalopathy <neurology, pathology> A condition which is used to describe the deleterious effects of liver failure on the central nervous system. Features include confusion ranging to unresponsiveness (coma). A common cause is alcoholic cirrhosis.
Treatment includes the binding and elimination of ammonia in the intestinal tract. General life support including respiratory support and cardiovascular support may also be required.
See: encephalopathy for additional details.
(27 Sep 1997)
saturnine encephalopathy A metabolic encephalopathy, caused by the ingestion of lead compounds and seen particularly in early childhood; it is characterised pathologically by extensive cerebral oedema, status spongiosus, neurocytolysis, and some reactive inflammation; clinical manifestations include convulsions, delirium, and hallucinations.
See: lead poisoning.
Synonym: lead encephalitis, saturnine encephalopathy.
(05 Mar 2000)
HIV encephalopathy <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting.
Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection.
(09 Oct 1997)
pulmonary encephalopathy Coma seen with advanced lung failure and resultant hypoventilation.
Synonym: CO2 narcosis, hypoxic-hypercarbic encephalopathy, pulmonary encephalopathy.
(05 Mar 2000)
severe postanoxic encephalopathy Coma that develops a few days to 3 weeks after an acute hypoxic insult; the latter was usually severe enough to cause an initial bout of coma, which cleared, and was followed by a transient interval of apparent normality.
Synonym: severe postanoxic encephalopathy.
(05 Mar 2000)
hypernatraemic encephalopathy Subarachnoid and subdural effusions in infants with hypernatraemic dehydration.
(05 Mar 2000)
hypertensive encephalopathy A metabolic encephalopathy caused by diffuse cerebral oedema; follows an abrupt elevation of blood pressure in a long-term hypertensive patient.
(05 Mar 2000)
hypoxic-hypercarbic encephalopathy Coma seen with advanced lung failure and resultant hypoventilation.
Synonym: CO2 narcosis, hypoxic-hypercarbic encephalopathy, pulmonary encephalopathy.
(05 Mar 2000)
hypoxic-ischemic encephalopathy Damage to cells in the central nervous system (the brain and spinal cord) from inadequate oxygen. Hypoxic-ischemic encephalopathy allegedly may cause in death in the newborn period or result in what is later recognised as developmental delay, mental retardation, or cerebral palsy. This is an area of considerable medical and medicolegal debate.
(12 Dec 1998)
spongiform encephalopathy An encephalopathy characterised by vacuolation within nerve and glial cells.
(05 Mar 2000)
necrotizing encephalopathy Subacute encephalomyelopathy affecting infants, causing dementia, spasticity, and optic atrophy; autosomal recessive inheritance.
Synonym: necrotizing encephalomyelopathy, necrotizing encephalopathy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á